Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends Jazz Pharmaceuticals’ Vyxeos to treat AML

pharmaceutical-technologyNovember 10, 2018

Tag: high-risk disease , AML-MRC , NICE , high-risk disease

PharmaSources Customer Service